ReviewJournal of clinical neurology (Seoul, Korea)2016

Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges.

Dana Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.